0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antisense Oligonucleotide Service Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-19G19173
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Antisense Oligonucleotide Service Market Research Report 2025
BUY CHAPTERS

Global Antisense Oligonucleotide Service Market Research Report 2025

Code: QYRE-Auto-19G19173
Report
March 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Antisense Oligonucleotide Service Market Size

The global market for Antisense Oligonucleotide Service was valued at US$ 1254 million in the year 2024 and is projected to reach a revised size of US$ 3265 million by 2031, growing at a CAGR of 15.7% during the forecast period.

Antisense Oligonucleotide Service Market

Antisense Oligonucleotide Service Market

Antisense oligonucleotide (ASO) is a short single-stranded DNA or RNA molecule, usually composed of 15-25 nucleotides. They regulate gene expression by complementary pairing with target mRNA, thereby inhibiting, restoring or modifying protein production. This report focuses on the Antisense Oligonucleotide Services Market. Antisense Oligonucleotide Service refers to the technical support and services provided for the research and development of antisense oligonucleotide drugs, including design, synthesis, modification, screening and verification.
North American market for Antisense Oligonucleotide Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Antisense Oligonucleotide Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Antisense Oligonucleotide Service in Drug Development is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Antisense Oligonucleotide Service include Creative Biogene, Charles River Laboratories, IDT, Creative Biolabs, Bio-Synthesis, Eurofins Genomics, GenScript, BOC Sciences, Danaher Life Sciences, Horizon Discovery, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Antisense Oligonucleotide Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antisense Oligonucleotide Service.
The Antisense Oligonucleotide Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antisense Oligonucleotide Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antisense Oligonucleotide Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Antisense Oligonucleotide Service Market Report

Report Metric Details
Report Name Antisense Oligonucleotide Service Market
Accounted market size in year US$ 1254 million
Forecasted market size in 2031 US$ 3265 million
CAGR 15.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Synthesis
  • Modification
  • Screening and Validation
  • Other
Segment by Application
  • Drug Development
  • Basic Research
  • Diagnosis and Treatment
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Creative Biogene, Charles River Laboratories, IDT, Creative Biolabs, Bio-Synthesis, Eurofins Genomics, GenScript, BOC Sciences, Danaher Life Sciences, Horizon Discovery, Microsynth - CH, Syngene International Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Antisense Oligonucleotide Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Antisense Oligonucleotide Service Market growing?

Ans: The Antisense Oligonucleotide Service Market witnessing a CAGR of 15.7% during the forecast period 2025-2031.

What is the Antisense Oligonucleotide Service Market size in 2031?

Ans: The Antisense Oligonucleotide Service Market size in 2031 will be US$ 3265 million.

Who are the main players in the Antisense Oligonucleotide Service Market report?

Ans: The main players in the Antisense Oligonucleotide Service Market are Creative Biogene, Charles River Laboratories, IDT, Creative Biolabs, Bio-Synthesis, Eurofins Genomics, GenScript, BOC Sciences, Danaher Life Sciences, Horizon Discovery, Microsynth - CH, Syngene International Ltd

What are the Application segmentation covered in the Antisense Oligonucleotide Service Market report?

Ans: The Applications covered in the Antisense Oligonucleotide Service Market report are Drug Development, Basic Research, Diagnosis and Treatment

What are the Type segmentation covered in the Antisense Oligonucleotide Service Market report?

Ans: The Types covered in the Antisense Oligonucleotide Service Market report are Synthesis, Modification, Screening and Validation, Other

Recommended Reports

Oligonucleotide Services

Oligonucleotide Therapeutics

RNA-based Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antisense Oligonucleotide Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Synthesis
1.2.3 Modification
1.2.4 Screening and Validation
1.2.5 Other
1.3 Market by Application
1.3.1 Global Antisense Oligonucleotide Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drug Development
1.3.3 Basic Research
1.3.4 Diagnosis and Treatment
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antisense Oligonucleotide Service Market Perspective (2020-2031)
2.2 Global Antisense Oligonucleotide Service Growth Trends by Region
2.2.1 Global Antisense Oligonucleotide Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Antisense Oligonucleotide Service Historic Market Size by Region (2020-2025)
2.2.3 Antisense Oligonucleotide Service Forecasted Market Size by Region (2026-2031)
2.3 Antisense Oligonucleotide Service Market Dynamics
2.3.1 Antisense Oligonucleotide Service Industry Trends
2.3.2 Antisense Oligonucleotide Service Market Drivers
2.3.3 Antisense Oligonucleotide Service Market Challenges
2.3.4 Antisense Oligonucleotide Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antisense Oligonucleotide Service Players by Revenue
3.1.1 Global Top Antisense Oligonucleotide Service Players by Revenue (2020-2025)
3.1.2 Global Antisense Oligonucleotide Service Revenue Market Share by Players (2020-2025)
3.2 Global Top Antisense Oligonucleotide Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antisense Oligonucleotide Service Revenue
3.4 Global Antisense Oligonucleotide Service Market Concentration Ratio
3.4.1 Global Antisense Oligonucleotide Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antisense Oligonucleotide Service Revenue in 2024
3.5 Global Key Players of Antisense Oligonucleotide Service Head office and Area Served
3.6 Global Key Players of Antisense Oligonucleotide Service, Product and Application
3.7 Global Key Players of Antisense Oligonucleotide Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antisense Oligonucleotide Service Breakdown Data by Type
4.1 Global Antisense Oligonucleotide Service Historic Market Size by Type (2020-2025)
4.2 Global Antisense Oligonucleotide Service Forecasted Market Size by Type (2026-2031)
5 Antisense Oligonucleotide Service Breakdown Data by Application
5.1 Global Antisense Oligonucleotide Service Historic Market Size by Application (2020-2025)
5.2 Global Antisense Oligonucleotide Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Antisense Oligonucleotide Service Market Size (2020-2031)
6.2 North America Antisense Oligonucleotide Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Antisense Oligonucleotide Service Market Size by Country (2020-2025)
6.4 North America Antisense Oligonucleotide Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antisense Oligonucleotide Service Market Size (2020-2031)
7.2 Europe Antisense Oligonucleotide Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Antisense Oligonucleotide Service Market Size by Country (2020-2025)
7.4 Europe Antisense Oligonucleotide Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antisense Oligonucleotide Service Market Size (2020-2031)
8.2 Asia-Pacific Antisense Oligonucleotide Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Antisense Oligonucleotide Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Antisense Oligonucleotide Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antisense Oligonucleotide Service Market Size (2020-2031)
9.2 Latin America Antisense Oligonucleotide Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Antisense Oligonucleotide Service Market Size by Country (2020-2025)
9.4 Latin America Antisense Oligonucleotide Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antisense Oligonucleotide Service Market Size (2020-2031)
10.2 Middle East & Africa Antisense Oligonucleotide Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Antisense Oligonucleotide Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Antisense Oligonucleotide Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Creative Biogene
11.1.1 Creative Biogene Company Details
11.1.2 Creative Biogene Business Overview
11.1.3 Creative Biogene Antisense Oligonucleotide Service Introduction
11.1.4 Creative Biogene Revenue in Antisense Oligonucleotide Service Business (2020-2025)
11.1.5 Creative Biogene Recent Development
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Details
11.2.2 Charles River Laboratories Business Overview
11.2.3 Charles River Laboratories Antisense Oligonucleotide Service Introduction
11.2.4 Charles River Laboratories Revenue in Antisense Oligonucleotide Service Business (2020-2025)
11.2.5 Charles River Laboratories Recent Development
11.3 IDT
11.3.1 IDT Company Details
11.3.2 IDT Business Overview
11.3.3 IDT Antisense Oligonucleotide Service Introduction
11.3.4 IDT Revenue in Antisense Oligonucleotide Service Business (2020-2025)
11.3.5 IDT Recent Development
11.4 Creative Biolabs
11.4.1 Creative Biolabs Company Details
11.4.2 Creative Biolabs Business Overview
11.4.3 Creative Biolabs Antisense Oligonucleotide Service Introduction
11.4.4 Creative Biolabs Revenue in Antisense Oligonucleotide Service Business (2020-2025)
11.4.5 Creative Biolabs Recent Development
11.5 Bio-Synthesis
11.5.1 Bio-Synthesis Company Details
11.5.2 Bio-Synthesis Business Overview
11.5.3 Bio-Synthesis Antisense Oligonucleotide Service Introduction
11.5.4 Bio-Synthesis Revenue in Antisense Oligonucleotide Service Business (2020-2025)
11.5.5 Bio-Synthesis Recent Development
11.6 Eurofins Genomics
11.6.1 Eurofins Genomics Company Details
11.6.2 Eurofins Genomics Business Overview
11.6.3 Eurofins Genomics Antisense Oligonucleotide Service Introduction
11.6.4 Eurofins Genomics Revenue in Antisense Oligonucleotide Service Business (2020-2025)
11.6.5 Eurofins Genomics Recent Development
11.7 GenScript
11.7.1 GenScript Company Details
11.7.2 GenScript Business Overview
11.7.3 GenScript Antisense Oligonucleotide Service Introduction
11.7.4 GenScript Revenue in Antisense Oligonucleotide Service Business (2020-2025)
11.7.5 GenScript Recent Development
11.8 BOC Sciences
11.8.1 BOC Sciences Company Details
11.8.2 BOC Sciences Business Overview
11.8.3 BOC Sciences Antisense Oligonucleotide Service Introduction
11.8.4 BOC Sciences Revenue in Antisense Oligonucleotide Service Business (2020-2025)
11.8.5 BOC Sciences Recent Development
11.9 Danaher Life Sciences
11.9.1 Danaher Life Sciences Company Details
11.9.2 Danaher Life Sciences Business Overview
11.9.3 Danaher Life Sciences Antisense Oligonucleotide Service Introduction
11.9.4 Danaher Life Sciences Revenue in Antisense Oligonucleotide Service Business (2020-2025)
11.9.5 Danaher Life Sciences Recent Development
11.10 Horizon Discovery
11.10.1 Horizon Discovery Company Details
11.10.2 Horizon Discovery Business Overview
11.10.3 Horizon Discovery Antisense Oligonucleotide Service Introduction
11.10.4 Horizon Discovery Revenue in Antisense Oligonucleotide Service Business (2020-2025)
11.10.5 Horizon Discovery Recent Development
11.11 Microsynth - CH
11.11.1 Microsynth - CH Company Details
11.11.2 Microsynth - CH Business Overview
11.11.3 Microsynth - CH Antisense Oligonucleotide Service Introduction
11.11.4 Microsynth - CH Revenue in Antisense Oligonucleotide Service Business (2020-2025)
11.11.5 Microsynth - CH Recent Development
11.12 Syngene International Ltd
11.12.1 Syngene International Ltd Company Details
11.12.2 Syngene International Ltd Business Overview
11.12.3 Syngene International Ltd Antisense Oligonucleotide Service Introduction
11.12.4 Syngene International Ltd Revenue in Antisense Oligonucleotide Service Business (2020-2025)
11.12.5 Syngene International Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Antisense Oligonucleotide Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Synthesis
 Table 3. Key Players of Modification
 Table 4. Key Players of Screening and Validation
 Table 5. Key Players of Other
 Table 6. Global Antisense Oligonucleotide Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Antisense Oligonucleotide Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Antisense Oligonucleotide Service Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Antisense Oligonucleotide Service Market Share by Region (2020-2025)
 Table 10. Global Antisense Oligonucleotide Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Antisense Oligonucleotide Service Market Share by Region (2026-2031)
 Table 12. Antisense Oligonucleotide Service Market Trends
 Table 13. Antisense Oligonucleotide Service Market Drivers
 Table 14. Antisense Oligonucleotide Service Market Challenges
 Table 15. Antisense Oligonucleotide Service Market Restraints
 Table 16. Global Antisense Oligonucleotide Service Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Antisense Oligonucleotide Service Market Share by Players (2020-2025)
 Table 18. Global Top Antisense Oligonucleotide Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Oligonucleotide Service as of 2024)
 Table 19. Ranking of Global Top Antisense Oligonucleotide Service Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Antisense Oligonucleotide Service Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Antisense Oligonucleotide Service, Headquarters and Area Served
 Table 22. Global Key Players of Antisense Oligonucleotide Service, Product and Application
 Table 23. Global Key Players of Antisense Oligonucleotide Service, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Antisense Oligonucleotide Service Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Antisense Oligonucleotide Service Revenue Market Share by Type (2020-2025)
 Table 27. Global Antisense Oligonucleotide Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Antisense Oligonucleotide Service Revenue Market Share by Type (2026-2031)
 Table 29. Global Antisense Oligonucleotide Service Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Antisense Oligonucleotide Service Revenue Market Share by Application (2020-2025)
 Table 31. Global Antisense Oligonucleotide Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Antisense Oligonucleotide Service Revenue Market Share by Application (2026-2031)
 Table 33. North America Antisense Oligonucleotide Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Antisense Oligonucleotide Service Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Antisense Oligonucleotide Service Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Antisense Oligonucleotide Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Antisense Oligonucleotide Service Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Antisense Oligonucleotide Service Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Antisense Oligonucleotide Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Antisense Oligonucleotide Service Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Antisense Oligonucleotide Service Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Antisense Oligonucleotide Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Antisense Oligonucleotide Service Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Antisense Oligonucleotide Service Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Antisense Oligonucleotide Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Antisense Oligonucleotide Service Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Antisense Oligonucleotide Service Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Creative Biogene Company Details
 Table 49. Creative Biogene Business Overview
 Table 50. Creative Biogene Antisense Oligonucleotide Service Product
 Table 51. Creative Biogene Revenue in Antisense Oligonucleotide Service Business (2020-2025) & (US$ Million)
 Table 52. Creative Biogene Recent Development
 Table 53. Charles River Laboratories Company Details
 Table 54. Charles River Laboratories Business Overview
 Table 55. Charles River Laboratories Antisense Oligonucleotide Service Product
 Table 56. Charles River Laboratories Revenue in Antisense Oligonucleotide Service Business (2020-2025) & (US$ Million)
 Table 57. Charles River Laboratories Recent Development
 Table 58. IDT Company Details
 Table 59. IDT Business Overview
 Table 60. IDT Antisense Oligonucleotide Service Product
 Table 61. IDT Revenue in Antisense Oligonucleotide Service Business (2020-2025) & (US$ Million)
 Table 62. IDT Recent Development
 Table 63. Creative Biolabs Company Details
 Table 64. Creative Biolabs Business Overview
 Table 65. Creative Biolabs Antisense Oligonucleotide Service Product
 Table 66. Creative Biolabs Revenue in Antisense Oligonucleotide Service Business (2020-2025) & (US$ Million)
 Table 67. Creative Biolabs Recent Development
 Table 68. Bio-Synthesis Company Details
 Table 69. Bio-Synthesis Business Overview
 Table 70. Bio-Synthesis Antisense Oligonucleotide Service Product
 Table 71. Bio-Synthesis Revenue in Antisense Oligonucleotide Service Business (2020-2025) & (US$ Million)
 Table 72. Bio-Synthesis Recent Development
 Table 73. Eurofins Genomics Company Details
 Table 74. Eurofins Genomics Business Overview
 Table 75. Eurofins Genomics Antisense Oligonucleotide Service Product
 Table 76. Eurofins Genomics Revenue in Antisense Oligonucleotide Service Business (2020-2025) & (US$ Million)
 Table 77. Eurofins Genomics Recent Development
 Table 78. GenScript Company Details
 Table 79. GenScript Business Overview
 Table 80. GenScript Antisense Oligonucleotide Service Product
 Table 81. GenScript Revenue in Antisense Oligonucleotide Service Business (2020-2025) & (US$ Million)
 Table 82. GenScript Recent Development
 Table 83. BOC Sciences Company Details
 Table 84. BOC Sciences Business Overview
 Table 85. BOC Sciences Antisense Oligonucleotide Service Product
 Table 86. BOC Sciences Revenue in Antisense Oligonucleotide Service Business (2020-2025) & (US$ Million)
 Table 87. BOC Sciences Recent Development
 Table 88. Danaher Life Sciences Company Details
 Table 89. Danaher Life Sciences Business Overview
 Table 90. Danaher Life Sciences Antisense Oligonucleotide Service Product
 Table 91. Danaher Life Sciences Revenue in Antisense Oligonucleotide Service Business (2020-2025) & (US$ Million)
 Table 92. Danaher Life Sciences Recent Development
 Table 93. Horizon Discovery Company Details
 Table 94. Horizon Discovery Business Overview
 Table 95. Horizon Discovery Antisense Oligonucleotide Service Product
 Table 96. Horizon Discovery Revenue in Antisense Oligonucleotide Service Business (2020-2025) & (US$ Million)
 Table 97. Horizon Discovery Recent Development
 Table 98. Microsynth - CH Company Details
 Table 99. Microsynth - CH Business Overview
 Table 100. Microsynth - CH Antisense Oligonucleotide Service Product
 Table 101. Microsynth - CH Revenue in Antisense Oligonucleotide Service Business (2020-2025) & (US$ Million)
 Table 102. Microsynth - CH Recent Development
 Table 103. Syngene International Ltd Company Details
 Table 104. Syngene International Ltd Business Overview
 Table 105. Syngene International Ltd Antisense Oligonucleotide Service Product
 Table 106. Syngene International Ltd Revenue in Antisense Oligonucleotide Service Business (2020-2025) & (US$ Million)
 Table 107. Syngene International Ltd Recent Development
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Antisense Oligonucleotide Service Picture
 Figure 2. Global Antisense Oligonucleotide Service Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Antisense Oligonucleotide Service Market Share by Type: 2024 VS 2031
 Figure 4. Synthesis Features
 Figure 5. Modification Features
 Figure 6. Screening and Validation Features
 Figure 7. Other Features
 Figure 8. Global Antisense Oligonucleotide Service Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Antisense Oligonucleotide Service Market Share by Application: 2024 VS 2031
 Figure 10. Drug Development Case Studies
 Figure 11. Basic Research Case Studies
 Figure 12. Diagnosis and Treatment Case Studies
 Figure 13. Antisense Oligonucleotide Service Report Years Considered
 Figure 14. Global Antisense Oligonucleotide Service Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Antisense Oligonucleotide Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Antisense Oligonucleotide Service Market Share by Region: 2024 VS 2031
 Figure 17. Global Antisense Oligonucleotide Service Market Share by Players in 2024
 Figure 18. Global Antisense Oligonucleotide Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 19. The Top 10 and 5 Players Market Share by Antisense Oligonucleotide Service Revenue in 2024
 Figure 20. North America Antisense Oligonucleotide Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Antisense Oligonucleotide Service Market Share by Country (2020-2031)
 Figure 22. United States Antisense Oligonucleotide Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Antisense Oligonucleotide Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Antisense Oligonucleotide Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Antisense Oligonucleotide Service Market Share by Country (2020-2031)
 Figure 26. Germany Antisense Oligonucleotide Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Antisense Oligonucleotide Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Antisense Oligonucleotide Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Antisense Oligonucleotide Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Antisense Oligonucleotide Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Antisense Oligonucleotide Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Antisense Oligonucleotide Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Antisense Oligonucleotide Service Market Share by Region (2020-2031)
 Figure 34. China Antisense Oligonucleotide Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Antisense Oligonucleotide Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Antisense Oligonucleotide Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Antisense Oligonucleotide Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Antisense Oligonucleotide Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Antisense Oligonucleotide Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Antisense Oligonucleotide Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Antisense Oligonucleotide Service Market Share by Country (2020-2031)
 Figure 42. Mexico Antisense Oligonucleotide Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Antisense Oligonucleotide Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Antisense Oligonucleotide Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Antisense Oligonucleotide Service Market Share by Country (2020-2031)
 Figure 46. Turkey Antisense Oligonucleotide Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Antisense Oligonucleotide Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Antisense Oligonucleotide Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Creative Biogene Revenue Growth Rate in Antisense Oligonucleotide Service Business (2020-2025)
 Figure 50. Charles River Laboratories Revenue Growth Rate in Antisense Oligonucleotide Service Business (2020-2025)
 Figure 51. IDT Revenue Growth Rate in Antisense Oligonucleotide Service Business (2020-2025)
 Figure 52. Creative Biolabs Revenue Growth Rate in Antisense Oligonucleotide Service Business (2020-2025)
 Figure 53. Bio-Synthesis Revenue Growth Rate in Antisense Oligonucleotide Service Business (2020-2025)
 Figure 54. Eurofins Genomics Revenue Growth Rate in Antisense Oligonucleotide Service Business (2020-2025)
 Figure 55. GenScript Revenue Growth Rate in Antisense Oligonucleotide Service Business (2020-2025)
 Figure 56. BOC Sciences Revenue Growth Rate in Antisense Oligonucleotide Service Business (2020-2025)
 Figure 57. Danaher Life Sciences Revenue Growth Rate in Antisense Oligonucleotide Service Business (2020-2025)
 Figure 58. Horizon Discovery Revenue Growth Rate in Antisense Oligonucleotide Service Business (2020-2025)
 Figure 59. Microsynth - CH Revenue Growth Rate in Antisense Oligonucleotide Service Business (2020-2025)
 Figure 60. Syngene International Ltd Revenue Growth Rate in Antisense Oligonucleotide Service Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI